From unicorn status to groundbreaking medical research, Flo Health has had one of the most impressive runs in the history of femtech. The world’s #1 downloaded women’s health app has been racking up achievements that signal a new era for digital women’s healthcare, and the press is taking notice.
Flo Health Becomes the First European Femtech Unicorn
Perhaps the biggest headline of the recent period: Flo Health secured more than $200 million in Series C funding from General Atlantic in July 2024, pushing the company’s valuation beyond $1 billion. The milestone made Flo the first purely digital consumer women’s health app, and the first European femtech company, to achieve unicorn status.
CEO and co-founder Dmitry Gurski called the achievement a landmark not just for Flo, but for the entire femtech industry. General Atlantic’s Jessie Cai described Flo as “a category leader,” pointing to the company’s deep focus on consumer technology, healthcare, and subscription-based services. The investment is earmarked for expanding into perimenopause and menopause support, scaling R&D teams across Europe and North America, and driving strategic growth opportunities.
Flo Health Hits 77 Million Monthly Active Users
With over 380 million lifetime downloads and 77 million monthly active users as of late 2024, Flo Health has cemented its status as one of the most used health platforms in the world, period. The company also reports nearly 5 million paid subscribers, with gross bookings expected to exceed $200 million in 2024 alone, representing a roughly 50% year-over-year increase. The numbers tell a story of explosive growth that few health apps have matched.
Flo Health Partners With Mayo Clinic on Landmark Perimenopause Study
In a major step forward for women’s health research, Flo Health collaborated with the Mayo Clinic to publish a first-of-its-kind global digital study on perimenopause awareness. The research, published in Menopause, the official journal of The Menopause Society, drew on responses from more than 17,000 women across 158 countries. The study found that fatigue, physical and mental exhaustion, and irritability were the most commonly reported symptoms among women in perimenopause, and revealed significant gaps in perimenopause knowledge, particularly in the United States.
The research reflects Flo Health’s growing role not just as a consumer app, but as a contributor to peer-reviewed science and global women’s health policy.
Flo Health Launches Dedicated Perimenopause Feature
Building on its research efforts, Flo Health launched “Flo for Perimenopause” in July 2025, a dedicated feature designed to support the more than 1 billion women worldwide who experience perimenopause. The feature delivers personalized guidance and educational content tailored to women who are entering, currently in, or curious about the perimenopause transition, expanding Flo’s reach into a demographic that has historically been underserved by digital health tools.
Former Match Group CEO Joins Flo Health’s Board
In January 2025, Flo Health announced that Mandy Ginsberg, former CEO of Match Group, joined its Board of Directors. Ginsberg brings decades of experience leading consumer technology platforms at scale, a signal that Flo is building the kind of leadership infrastructure expected of a company with global ambitions. The appointment was widely covered as a vote of confidence in Flo’s strategic direction.
Flo Health Wins Google Play Best of 2025 Award
To kick off 2026, Flo Health received recognition from Google Play’s annual Best of 2025 Awards program, earning the “Best for Watches” distinction across Hong Kong, Taiwan, and Macau. Google Play highlighted the award as a celebration of developers who push boundaries and consistently deliver high-quality updates, a description that fits Flo’s track record in wearable integration and cycle-tracking innovation.
The Bottom Line on Flo Health
Whether it’s landmark research partnerships, record user growth, high-profile board appointments, or industry awards, Flo Health continues to generate press coverage that reflects genuine momentum. As the company deepens its presence in perimenopause, AI-powered health insights, and global access programs, all signs point to Flo Health’s most significant chapter still ahead.
